KR19980073479A - 사이클로스포린-함유 연질캅셀제 - Google Patents
사이클로스포린-함유 연질캅셀제 Download PDFInfo
- Publication number
- KR19980073479A KR19980073479A KR1019970008750A KR19970008750A KR19980073479A KR 19980073479 A KR19980073479 A KR 19980073479A KR 1019970008750 A KR1019970008750 A KR 1019970008750A KR 19970008750 A KR19970008750 A KR 19970008750A KR 19980073479 A KR19980073479 A KR 19980073479A
- Authority
- KR
- South Korea
- Prior art keywords
- cyclosporin
- soft capsule
- surfactant
- containing soft
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title claims abstract description 77
- 108010036949 Cyclosporine Proteins 0.000 title claims abstract description 77
- 229960001265 ciclosporin Drugs 0.000 title claims abstract description 72
- 229930182912 cyclosporin Natural products 0.000 title claims abstract description 70
- 239000007901 soft capsule Substances 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 claims abstract description 78
- 229930105110 Cyclosporin A Natural products 0.000 claims abstract description 50
- 239000004094 surface-active agent Substances 0.000 claims abstract description 40
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000003921 oil Substances 0.000 claims abstract description 32
- 239000000194 fatty acid Substances 0.000 claims abstract description 30
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 28
- 229930195729 fatty acid Natural products 0.000 claims abstract description 28
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 26
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 26
- 239000004064 cosurfactant Substances 0.000 claims abstract description 20
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 5
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims abstract description 4
- -1 fatty acid triglycerides Chemical class 0.000 claims description 37
- 235000019198 oils Nutrition 0.000 claims description 29
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 16
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 13
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 13
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 11
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 11
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 11
- 239000005642 Oleic acid Substances 0.000 claims description 11
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 11
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 239000004359 castor oil Substances 0.000 claims description 10
- 235000019438 castor oil Nutrition 0.000 claims description 10
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 8
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 claims description 8
- 229940031016 ethyl linoleate Drugs 0.000 claims description 8
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 claims description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 8
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 8
- 239000004014 plasticizer Substances 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical group CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- JNODDICFTDYODH-UHFFFAOYSA-N 2-hydroxytetrahydrofuran Chemical compound OC1CCCO1 JNODDICFTDYODH-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 238000009472 formulation Methods 0.000 description 17
- 239000002775 capsule Substances 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 108010010803 Gelatin Proteins 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000004443 Ricinus communis Nutrition 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000001189 Cyclic Peptides Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- JTOKYIBTLUQVQV-QRVTZXGZSA-N (3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-30-[(1r)-1-hydroxyethyl]-33-[(e,1r,2r)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontan Chemical compound C\C=C\C[C@@H](C)[C@@H](O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H]([C@@H](C)O)NC1=O JTOKYIBTLUQVQV-QRVTZXGZSA-N 0.000 description 1
- UCOQITKXMNKTKF-MXGZYYNMSA-N (3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-33-[(e,1r,2r)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28,30-decamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23 Chemical compound C\C=C\C[C@@H](C)[C@@H](O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](C)NC1=O UCOQITKXMNKTKF-MXGZYYNMSA-N 0.000 description 1
- ZNVBEWJRWHNZMK-SYOLRUPNSA-N (3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-33-[(e,1r,2r)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,2 Chemical compound C\C=C\C[C@@H](C)[C@@H](O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](C(C)C)NC1=O ZNVBEWJRWHNZMK-SYOLRUPNSA-N 0.000 description 1
- ZMKGDQSIRSGUDJ-VSROPUKISA-N (3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-33-[(e,1r,2r)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,1 Chemical compound CCC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O ZMKGDQSIRSGUDJ-VSROPUKISA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 108010036941 Cyclosporins Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229960002479 isosorbide Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008180 pharmaceutical surfactant Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (75)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019970008750A KR19980073479A (ko) | 1997-03-14 | 1997-03-14 | 사이클로스포린-함유 연질캅셀제 |
| BR9706804-7A BR9706804A (pt) | 1996-06-19 | 1997-06-19 | Preparações de cápsula macia contendo ciclosporina. |
| NZ330062A NZ330062A (en) | 1996-06-19 | 1997-06-19 | composition containing cyclosporin, propylene carbonate, an oil component and a surfactant |
| MYPI97002776A MY117765A (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing soft capsule preparations. |
| SK372-98A SK283361B6 (sk) | 1996-06-19 | 1997-06-19 | Prípravok vo forme mäkkej kapsuly obsahujúci cyklosporín |
| RU98105629/14A RU2181055C2 (ru) | 1996-06-19 | 1997-06-19 | Препараты, содержащие циклоспорин, в виде капсул с мягким покрытием |
| KR1019980710368A KR20000016761A (ko) | 1996-06-19 | 1997-06-19 | 사이클로스포린-함유 연질캅셀제 |
| AT03029109T ATE392891T1 (de) | 1996-06-19 | 1997-06-19 | Cyclosporin enthaltende präparate |
| AT97929227T ATE278412T1 (de) | 1996-06-19 | 1997-06-19 | Cyclosporin enthaltende weichkapselpräparate |
| SK371-98A SK283216B6 (sk) | 1996-06-19 | 1997-06-19 | Prípravok obsahujúci cyklosporín a spôsob jeho prípravy |
| SI9720010A SI9720010B (sl) | 1996-06-19 | 1997-06-19 | Ciklosporin vsebujoči mehki kapsulni pripravki |
| TR1998/00526T TR199800526T2 (xx) | 1996-06-19 | 1997-06-19 | Siklosporin i�erikli yumu�ak kaps�l terkipleri. |
| CA002240705A CA2240705C (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing soft capsule preparations |
| ES97929227T ES2227700T3 (es) | 1996-06-19 | 1997-06-19 | Preparados de capsulas blandas que contienen ciclosporina. |
| SG9901629A SG88752A1 (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing soft capsule preparations |
| EP03029109A EP1413297B1 (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing preparations |
| PT97929227T PT869810E (pt) | 1996-06-19 | 1997-06-19 | Preparacoes de capsulas moles contendo ciclosporina |
| ES03029109T ES2305396T3 (es) | 1996-06-19 | 1997-06-19 | Preparaciones que contienen ciclosporina. |
| RU98106393/14A RU2185187C2 (ru) | 1996-06-19 | 1997-06-19 | Препарат, содержащий циклоспорин (варианты), и способ его получения |
| IL12367697A IL123676A (en) | 1996-06-19 | 1997-06-19 | A medicinal preparation in the form of a soft capsule containing cyclosporine |
| EP97929227A EP0869810B1 (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing soft capsule preparations |
| DE69731072T DE69731072T2 (de) | 1996-06-19 | 1997-06-19 | Cyclosporin enthaltende weichkapselpräparate |
| HU9801109A HUP9801109A3 (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing soft capsule preparations |
| PL97325832A PL188500B1 (pl) | 1996-06-19 | 1997-06-19 | Preparaty w postaci miękkich kapsułek zawierającecyklosporynę |
| AU33411/97A AU719251B2 (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing soft capsule preparations |
| CN97191060A CN1127350C (zh) | 1996-06-19 | 1997-06-19 | 含有环孢菌素的软胶囊制剂 |
| DE69738656T DE69738656T2 (de) | 1996-06-19 | 1997-06-19 | Cyclosporin enthaltende Präparate |
| IL12384097A IL123840A (en) | 1996-06-19 | 1997-06-19 | Preparations containing cyclosporine |
| IL14736997A IL147369A (en) | 1996-06-19 | 1997-06-19 | Preparations containing cyclosporine |
| PCT/EP1997/003213 WO1997048410A1 (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing soft capsule preparations |
| BR9713811-8A BR9713811A (pt) | 1996-06-19 | 1997-06-19 | Preparações de cápsula macia contendo ciclosporina |
| CNA2003101142054A CN1494920A (zh) | 1996-06-19 | 1997-06-19 | 含有环孢菌素的软胶囊制剂 |
| CA002226091A CA2226091C (en) | 1996-06-19 | 1997-06-19 | Cyclosporin-containing soft capsule preparations |
| JP50229798A JP3519414B2 (ja) | 1996-06-19 | 1997-06-19 | サイクロポリン含有軟質カプセル製剤 |
| KR10-2003-7000108A KR20040000379A (ko) | 1996-06-19 | 1997-06-19 | 사이클로스포린-함유 연질캅셀제 |
| PT03029109T PT1413297E (pt) | 1996-06-19 | 1997-06-19 | Preparações contendo ciclosporina |
| CZ1998834A CZ291641B6 (cs) | 1996-06-19 | 1997-06-19 | Přípravek obsahující cyklosporin |
| TR1998/00525T TR199800525T2 (xx) | 1996-06-19 | 1997-06-19 | Siklosporin i�erikli yumu�ak kaps�l terkipleri. |
| CZ1998835A CZ292378B6 (cs) | 1996-06-19 | 1997-06-19 | Přípravek obsahující cyklosporin a způsob jeho přípravy |
| DK97929227T DK0869810T3 (da) | 1996-06-19 | 1997-06-19 | Cyclosporinholdige blöde kapselpræparater |
| SI9720011A SI9720011A (sl) | 1996-06-19 | 1997-06-19 | Ciklosporin vsebujoči mehki kapsulni pripravki |
| CNB988033569A CN1161150C (zh) | 1997-03-14 | 1998-03-12 | 药物组合物 |
| JP54011298A JP3748573B2 (ja) | 1997-03-14 | 1998-03-12 | 医薬用組成物 |
| ZA982117A ZA982117B (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions |
| AU67293/98A AU741923B2 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions |
| PE1998000174A PE59499A1 (es) | 1997-03-14 | 1998-03-12 | Composicion farmaceutica de ciclosporina |
| GB9921495A GB2337703A (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions |
| RU99121398/14A RU2185188C2 (ru) | 1997-03-14 | 1998-03-12 | Фармацевтические композиции |
| PCT/EP1998/001432 WO1998041225A1 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions |
| PL98335729A PL335729A1 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutic compositions |
| MYPI98001086A MY118614A (en) | 1997-03-14 | 1998-03-12 | Cyclosporin-containing pharmaceutical compositions |
| US09/041,456 US5958876A (en) | 1996-06-19 | 1998-03-12 | Cyclosporin-containing pharmaceutical compositions |
| EP98912470A EP0969857A1 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions |
| CZ993243A CZ324399A3 (cs) | 1997-03-14 | 1998-03-12 | Farmaceutické prostředky obsahující cyklosporin |
| HU0001515A HUP0001515A3 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions containing cyclosporin |
| SK1232-99A SK123299A3 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions containing cyclosporin |
| IDW990997A ID23531A (id) | 1997-03-14 | 1998-03-12 | Komposisi farmasi |
| KR1019997008022A KR20000075940A (ko) | 1997-03-14 | 1998-03-12 | 제약 조성물 |
| IL13170398A IL131703A0 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions in the form of soft gelatine capsule containing cyclosporin |
| CA002283901A CA2283901A1 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions |
| TR1999/02229T TR199902229T2 (xx) | 1997-03-14 | 1998-03-12 | Farmakolojik kompozisyonlar. |
| BR9808324-4A BR9808324A (pt) | 1997-03-14 | 1998-03-12 | Composições farmacêuticas |
| DE19882184T DE19882184T1 (de) | 1997-03-14 | 1998-03-12 | Cyclosporin enthaltende Präparation |
| CO98014254A CO4940404A1 (es) | 1997-03-14 | 1998-03-13 | Composiciones farmaceuticas |
| ARP980101125A AR012054A1 (es) | 1997-03-14 | 1998-03-13 | Una composiciones farmaceutica |
| NO19981200A NO321921B1 (no) | 1996-06-19 | 1998-03-17 | Cyklosporinholdige myk-kapsel-preparater |
| IL12384098A IL123840A0 (en) | 1996-06-19 | 1998-03-26 | Cyclosporin-containing soft capsule preparations |
| NO19982382A NO323816B1 (no) | 1996-06-19 | 1998-05-26 | Cyklosporinholdige preparater |
| MX9804414A MX9804414A (es) | 1996-06-19 | 1998-06-03 | Preparaciones de capsula blanda que contienen ciclosporina. |
| MX9804442A MX9804442A (es) | 1996-06-19 | 1998-06-04 | Preparaciones de capsula blanda que contienen ciclosporina. |
| HK98111747.6A HK1010492B (en) | 1996-06-19 | 1998-11-04 | Cyclosporin-containing soft capsule preparations |
| NO994436A NO994436L (no) | 1997-03-14 | 1999-09-13 | Farmasöytiske sammensetninger |
| IL14736901A IL147369A0 (en) | 1996-06-19 | 2001-12-27 | Cyclosporin-containing preparations |
| JP2003376460A JP2004043511A (ja) | 1996-06-19 | 2003-11-06 | サイクロスポリン含有軟質カプセル製剤 |
| CY0600003A CY2549B1 (en) | 1996-06-19 | 2006-02-13 | Cyclosporin containing soft capsule preparations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019970008750A KR19980073479A (ko) | 1997-03-14 | 1997-03-14 | 사이클로스포린-함유 연질캅셀제 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019990065526A Division KR20060086489A (ko) | 1999-12-30 | 1999-12-30 | 사이클로스포린-함유 연질캅셀제 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR19980073479A true KR19980073479A (ko) | 1998-11-05 |
Family
ID=19499792
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970008750A Ceased KR19980073479A (ko) | 1996-06-19 | 1997-03-14 | 사이클로스포린-함유 연질캅셀제 |
| KR1019997008022A Ceased KR20000075940A (ko) | 1997-03-14 | 1998-03-12 | 제약 조성물 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019997008022A Ceased KR20000075940A (ko) | 1997-03-14 | 1998-03-12 | 제약 조성물 |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0969857A1 (cs) |
| JP (1) | JP3748573B2 (cs) |
| KR (2) | KR19980073479A (cs) |
| CN (1) | CN1161150C (cs) |
| AR (1) | AR012054A1 (cs) |
| AU (1) | AU741923B2 (cs) |
| BR (1) | BR9808324A (cs) |
| CA (1) | CA2283901A1 (cs) |
| CO (1) | CO4940404A1 (cs) |
| CZ (1) | CZ324399A3 (cs) |
| DE (1) | DE19882184T1 (cs) |
| GB (1) | GB2337703A (cs) |
| HU (1) | HUP0001515A3 (cs) |
| ID (1) | ID23531A (cs) |
| IL (1) | IL131703A0 (cs) |
| MY (1) | MY118614A (cs) |
| NO (1) | NO994436L (cs) |
| PE (1) | PE59499A1 (cs) |
| PL (1) | PL335729A1 (cs) |
| RU (1) | RU2185188C2 (cs) |
| SK (1) | SK123299A3 (cs) |
| TR (1) | TR199902229T2 (cs) |
| WO (1) | WO1998041225A1 (cs) |
| ZA (1) | ZA982117B (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2380674B (en) * | 1998-03-06 | 2003-05-28 | Novartis Ag | Emulsion preconcentrates containing cyclosporin or a macrolide |
| US7203158B2 (en) * | 2000-12-06 | 2007-04-10 | Matsushita Electric Industrial Co., Ltd. | OFDM signal transmission system, portable terminal, and e-commerce system |
| GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5603951A (en) * | 1994-11-09 | 1997-02-18 | Hanmi Pharm. Ind. Co., Ltd. | Cyclosporin-containing soft capsule compositions |
| HU215966B (hu) * | 1994-11-21 | 1999-07-28 | BIOGAL Gyógyszergyár Rt. | Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum |
| KR0167613B1 (ko) * | 1994-12-28 | 1999-01-15 | 한스 루돌프 하우스, 니콜 케르커 | 사이클로스포린-함유 연질캅셀제 조성물 |
| US6465627B2 (en) * | 1995-07-28 | 2002-10-15 | The Regents Of The University Of California | DAX-1 protein, methods for production and use thereof |
| NZ280689A (en) * | 1995-12-15 | 1997-08-22 | Bernard Charles Sherma Sherman | Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol |
| CZ292378B6 (cs) * | 1996-06-19 | 2003-09-17 | Novartis Ag | Přípravek obsahující cyklosporin a způsob jeho přípravy |
| KR0183449B1 (ko) * | 1996-06-19 | 1999-05-01 | 한스 루돌프 하우스, 니콜 케르커 | 사이클로스포린-함유 연질캅셀제 |
-
1997
- 1997-03-14 KR KR1019970008750A patent/KR19980073479A/ko not_active Ceased
-
1998
- 1998-03-12 CZ CZ993243A patent/CZ324399A3/cs unknown
- 1998-03-12 GB GB9921495A patent/GB2337703A/en not_active Withdrawn
- 1998-03-12 CA CA002283901A patent/CA2283901A1/en not_active Abandoned
- 1998-03-12 SK SK1232-99A patent/SK123299A3/sk unknown
- 1998-03-12 KR KR1019997008022A patent/KR20000075940A/ko not_active Ceased
- 1998-03-12 EP EP98912470A patent/EP0969857A1/en not_active Withdrawn
- 1998-03-12 RU RU99121398/14A patent/RU2185188C2/ru not_active IP Right Cessation
- 1998-03-12 WO PCT/EP1998/001432 patent/WO1998041225A1/en not_active Application Discontinuation
- 1998-03-12 BR BR9808324-4A patent/BR9808324A/pt not_active Application Discontinuation
- 1998-03-12 CN CNB988033569A patent/CN1161150C/zh not_active Expired - Fee Related
- 1998-03-12 PE PE1998000174A patent/PE59499A1/es not_active Application Discontinuation
- 1998-03-12 MY MYPI98001086A patent/MY118614A/en unknown
- 1998-03-12 HU HU0001515A patent/HUP0001515A3/hu unknown
- 1998-03-12 DE DE19882184T patent/DE19882184T1/de not_active Withdrawn
- 1998-03-12 ZA ZA982117A patent/ZA982117B/xx unknown
- 1998-03-12 ID IDW990997A patent/ID23531A/id unknown
- 1998-03-12 TR TR1999/02229T patent/TR199902229T2/xx unknown
- 1998-03-12 AU AU67293/98A patent/AU741923B2/en not_active Ceased
- 1998-03-12 JP JP54011298A patent/JP3748573B2/ja not_active Expired - Fee Related
- 1998-03-12 IL IL13170398A patent/IL131703A0/xx unknown
- 1998-03-12 PL PL98335729A patent/PL335729A1/xx unknown
- 1998-03-13 AR ARP980101125A patent/AR012054A1/es not_active Application Discontinuation
- 1998-03-13 CO CO98014254A patent/CO4940404A1/es unknown
-
1999
- 1999-09-13 NO NO994436A patent/NO994436L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998041225A1 (en) | 1998-09-24 |
| SK123299A3 (en) | 2000-02-14 |
| CN1250378A (zh) | 2000-04-12 |
| JP3748573B2 (ja) | 2006-02-22 |
| AU6729398A (en) | 1998-10-12 |
| EP0969857A1 (en) | 2000-01-12 |
| NO994436D0 (no) | 1999-09-13 |
| NO994436L (no) | 1999-09-13 |
| TR199902229T2 (xx) | 1999-12-21 |
| CA2283901A1 (en) | 1998-09-24 |
| MY118614A (en) | 2004-12-31 |
| ZA982117B (en) | 1998-09-14 |
| GB9921495D0 (en) | 1999-11-17 |
| PE59499A1 (es) | 1999-07-05 |
| PL335729A1 (en) | 2000-05-08 |
| JP2000514831A (ja) | 2000-11-07 |
| KR20000075940A (ko) | 2000-12-26 |
| HUP0001515A3 (en) | 2000-10-30 |
| DE19882184T1 (de) | 2000-02-10 |
| CN1161150C (zh) | 2004-08-11 |
| CO4940404A1 (es) | 2000-07-24 |
| GB2337703A (en) | 1999-12-01 |
| AU741923B2 (en) | 2001-12-13 |
| IL131703A0 (en) | 2001-03-19 |
| CZ324399A3 (cs) | 1999-12-15 |
| ID23531A (id) | 2000-04-27 |
| RU2185188C2 (ru) | 2002-07-20 |
| AR012054A1 (es) | 2000-09-27 |
| HUP0001515A2 (hu) | 2000-09-28 |
| BR9808324A (pt) | 2000-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0167613B1 (ko) | 사이클로스포린-함유 연질캅셀제 조성물 | |
| KR0167696B1 (ko) | 사이클로스포린-함유 연질캅셀제 조성물 | |
| KR0150830B1 (ko) | 사이클로스포린 연질캅셀제 조성물 | |
| US5639474A (en) | Cyclosporin soft capsule composition | |
| KR0183449B1 (ko) | 사이클로스포린-함유 연질캅셀제 | |
| KR980008239A (ko) | 사이클로스포린-함유 약학적 조성물 | |
| US5958876A (en) | Cyclosporin-containing pharmaceutical compositions | |
| KR20000016761A (ko) | 사이클로스포린-함유 연질캅셀제 | |
| KR100304326B1 (ko) | 사이클로스포린-함유마이크로에멀젼예비농축액조성물 | |
| KR19980073479A (ko) | 사이클로스포린-함유 연질캅셀제 | |
| KR100525234B1 (ko) | 사이클로스포린 함유 연질캅셀제 및 그 제조방법 | |
| KR100464617B1 (ko) | 사이클로스포린-함유연질캅셀제 | |
| KR20060086489A (ko) | 사이클로스포린-함유 연질캅셀제 | |
| AU753018B2 (en) | Cyclosporin-containing soft capsule preparations | |
| HK1006780B (en) | Cyclosporin-containing soft capsule preparations | |
| MXPA99008438A (en) | Pharmaceutical compositions | |
| KR19990066706A (ko) | 사이클로스포린-함유 마이크로에멀젼 예비농축액 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19970314 |
|
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19970314 Comment text: Request for Examination of Application |
|
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
Patent event date: 19980321 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19990223 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19990830 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19990223 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 19991202 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 19990830 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20011031 Appeal identifier: 1999101004461 Request date: 19991202 |
|
| A107 | Divisional application of patent | ||
| PA0107 | Divisional application |
Comment text: Divisional Application of Patent Patent event date: 19991230 Patent event code: PA01071R01D |
|
| PB0901 | Examination by re-examination before a trial |
Comment text: Request for Trial against Decision on Refusal Patent event date: 19991202 Patent event code: PB09011R01I |
|
| J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 19991202 Effective date: 20011031 Free format text: TRIAL NUMBER: 1999101004461; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 19991202 Effective date: 20011031 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S01D Patent event date: 20011031 Comment text: Trial Decision on Objection to Decision on Refusal Appeal kind category: Appeal against decision to decline refusal Request date: 19991202 Decision date: 20011031 Appeal identifier: 1999101004461 |